Detalhe da pesquisa
1.
Endocannabinoid-related molecules predict the metabolic efficacy of GLP-1 receptor agonism in humans with obesity.
J Endocrinol Invest
; 2023 Nov 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-37924474
2.
Chronic intrahypothalamic rather than subcutaneous liraglutide treatment reduces body weight gain and stimulates the melanocortin receptor system.
Int J Obes (Lond)
; 41(8): 1263-1270, 2017 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-28507313
3.
Treatment with a GLP-1 receptor agonist diminishes the decrease in free plasma leptin during maintenance of weight loss.
Int J Obes (Lond)
; 39(5): 834-41, 2015 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-25287751
4.
Dose response of continuous subcutaneous infusion of recombinant glucagon-like peptide-1 in combination with metformin and sulphonylurea over 12 weeks in patients with type 2 diabetes mellitus.
Diabetes Obes Metab
; 16(5): 451-6, 2014 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-24251641
5.
Homozygous carriers of the G allele of rs4664447 of the glucagon gene (GCG) are characterised by decreased fasting and stimulated levels of insulin, glucagon and glucagon-like peptide (GLP)-1.
Diabetologia
; 54(11): 2820-31, 2011 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-21822931
6.
Dose response of subcutaneous GLP-1 infusion in patients with type 2 diabetes.
Diabetes Obes Metab
; 13(7): 639-43, 2011 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-21362122
7.
An overview of once-weekly glucagon-like peptide-1 receptor agonists--available efficacy and safety data and perspectives for the future.
Diabetes Obes Metab
; 13(5): 394-407, 2011 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-21208359
8.
Treatment with liraglutide may improve markers of CVD reflected by reduced levels of apoB.
Obes Sci Pract
; 3(4): 425-433, 2017 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-29259801
9.
A functional amino acid substitution in the glucose-dependent insulinotropic polypeptide receptor (GIPR) gene is associated with lower bone mineral density and increased fracture risk.
J Clin Endocrinol Metab
; 99(4): E729-33, 2014 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-24446656
10.
Impact of postprandial glycaemia on health and prevention of disease.
Obes Rev
; 13(10): 923-84, 2012 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-22780564
11.
Obesity - an indication for GLP-1 treatment? Obesity pathophysiology and GLP-1 treatment potential.
Obes Rev
; 12(8): 593-601, 2011 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-21401851
12.
Genetic analysis of the estrogen-related receptor alpha and studies of association with obesity and type 2 diabetes.
Int J Obes (Lond)
; 31(2): 365-70, 2007 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-16755280
13.
Variants in the 5' region of the neuropeptide Y receptor Y2 gene (NPY2R) are associated with obesity in 5,971 white subjects.
Diabetologia
; 49(11): 2653-8, 2006 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-17019604